Maternal Nanos (Nos) protein is required for germline development in Drosophila embryos. Here we show that Nos regulates zygotic gene expression in the germline progenitors, or pole cells. In order to probe the gene expression in pole cells, we screened ten enhancer-trap lines which showed b-gal expression in pole cells. All of these enhancer-trap markers were fully activated in pole cells after their migration to the embryonic gonads. In the pole cells lacking Nos, the expression of nine out of ten enhancer-trap markers was affected. Among nine markers, five (Type-A) were prematurely expressed in the pole cells during the course of their migration. The expression of other four markers (Type-B) initiated correctly after pole-cell migration, but their expression was significantly reduced. Thus, we conclude that the maternal Nos plays a dual role in zygotic gene regulation in pole cells: to define the stages of expression for Type-A markers, and to enhance expression for Type-B markers. Contrary to our results, Heller and Steinmann-Zwicky (1998) have recently reported that no premature expression of Type-A markers occurs in the pole cells of embryos derived from nos mutant females. This discrepancy is due to the difference in the nos mutant alleles used for these analyses. We used the much stronger allele, nos BN .
Introduction
In many developmental processes, maternal factors localized in a portion of egg cytoplasm are required to produce topologically restricted, diversely committed cell lineages. In Drosophila, germ plasm localized in the posterior pole region of the egg contains maternal factors sufficient for germline formation, and is later partitioned into the germline progenitors, or pole cells (Illmensee and Mahowald, 1974; Illmensee and Mahowald, 1976; Okada et al., 1974; St. Johnston, 1993) . It has been believed that the germlineforming factors ultimately regulate zygotic gene expression that functions in pole cells for their development into functional germ cells. However, little is known about how the maternal factors regulate gene expression in pole cells.
Among the maternal factors identified so far, Nanos (Nos) is the only molecule that affects gene expression in pole cells (Kobayashi et al., 1996) . The nos mRNA localized in germ plasm is translated in situ to form a gradient of Nos protein with its highest concentration in germ plasm. The Nos protein is present transiently in the abdominal rudiment, and becomes undetectable by the cellular blastodermal stage. In contrast, Nos in germ plasm is partitioned into pole cells and remains detectable during pole-cell migration until they reach the gonads (Wang et al., 1994) . In the absence of maternal Nos, the embryos normally form pole cells. However, the pole cells lacking Nos fail to migrate into the embryonic gonads and consequently, do not differentiate as functional germ cells (Kobayashi et al., 1996; Forbes and Lehmann, 1998) . In such pole cells, the expression of three enhancer-trap markers, which normally initiates when pole cells are incorporated within the Mechanisms of Development 78 (1998) 153-158 0925-4773/98/$ -see front matter © 1998 Elsevier Science Ireland Ltd. All rights reserved PII S0925-4773(98)00164-6 gonads, begins prematurely during early embryogenesis (Kobayashi et al., 1996) .
Here, we described the identification of molecular markers for examining zygotic gene expression in pole cells lacking Nos. We obtained ten enhancer-trap lines which showed b-gal expression in pole cells after their migration into the embryonic gonads. In the absence of Nos, the expression of nine out of ten enhancer-trap markers was affected. These results indicate that the maternal Nos plays a central role in regulating zygotic gene expression in pole cells. We discuss the mechanism of how Nos controls the gene expression in pole cells.
Results

Screening of enhancer-trap lines showing b-gal expression in germline
In order to obtain the molecular markers for examining the gene expression in pole cells, we used a P-elementmediated enhancer-trap technique (O'Kane and Gehring, 1987; Bellen et al., 1989; Bier et al., 1989) . The embryos carrying single lacZ-reporter gene at different loci were stained with X-gal to determine the temporal and spatial expressions of the reporter gene. From 1590 independent enhancer-trap lines, we identified ten lines which showed b-galactosidase (b-gal) expression in pole cells during embryogenesis ( Table 1 ). All of these enhancer-trap markers started to be expressed in pole cells at stages 12-14, and were fully activated after the completion of their migration to the embryonic gonads (stages 15-17) ( Table 2 ). In the late embryos, almost all pole cells expressed the enhancer-trap markers, regardless of whether pole cells were incorporated within the gonads or left outside of the gonads (Table 3 ). This suggests that their expression is not influenced by the cellular environment around pole cells.
The expression of the enhancer-trap markers in pole cells of nos embryos
We next examined whether the expression of these enhancer-trap markers was affected in the absence of maternal Nos. Because Heller and Steinmann-Zwicky (1998) have reported that the pole cells remained outside of nos embryos showed an artifactual X-gal staining, we examined the expression of the enhancer-trap markers in pole cells which correctly moved into the embryos. Among ten enhancer-trap markers, only one marker (4474) was normally expressed in pole cells, independent of Nos activity (Table 2, Figs. 1 and 2). Other nine markers showed the altered expression in pole cells of the embryos derived from the females homozygous for maternal nos mutation (we hereafter refer to these embryos as nos embryos, and the pole cells formed in these embryos as nos pole cells) ( Table 2) .
Among nine enhancer-trap markers, five (198, 640, 3845, 4314 , and 4351; we called these markers as Type-A markers) were expressed prematurely in nos pole cells. The expression of 198, 640, and 4351 markers in nos pole Kobayashi et al. (1996) . d This line is homozygous lethal. All the other lines are homozygous viable and fertile. /TM3 females mated with males of the enhancertrap lines. The expression was examined by staining with X-gal and an anti-b-gal antibody. a The stages when the percentages of embryos with stained pole cells became more than 10% were described (total no. of embryos examined at the assigned stages: 16-87). b The b-gal expression was undetectable until the first instar larval stage in the embryos derived from nos/TM3 females mated with the enhancer-trap line. c Less than 4% of embryos showed b-gal expression at stages 14-17 (total no. of embryos examined: 179).
cells has been reported in our previous report (Kobayashi et al., 1996) . Here, we confirmed our previous observations using an immuno-histochemical detection for b-gal (Fig.  3) . The expression of Type-A markers initiated in nos pole cells at around stage 8, and remained detectable until at least the completion of embryogenesis (Table 2, Figs. 1 and 2). The intensity of the marker expression in nos pole cells was unaffected (Table 2) . Thus, the maternal Nos is required to define the stages of their expression, but is dispensable for their activation. In contrast to Type-A markers, remaining 4 markers (734, 755, 3914 and 4514, called as Type-B markers) were never expressed prematurely in nos pole cells, but rather their expression initiated almost identically to that observed in normal pole cells (Table 2, Figs. 1 and 2). However, the percentages of embryos with the pole cells expressing these markers significantly decreased in the absence of Nos (Fig. 1) . In addition, these pole cells can be distinguished from normal pole cells due to apparently weaker expression of these markers. Thus, Nos is required to promote the expression of Type-B markers, but is dispensable to define the stages of their expression.
Discussion
In this study, we have identified ten enhancer-trap markers that are expressed in pole cells during embryogenesis. Among ten markers, nine showed the altered expression in nos pole cells. This observation suggests that maternal Nos has a central role in the regulation of zygotic gene expression in pole cells. However, this does not mean that Nos regulates general transcription, since the 4474-marker expression is unaffected even in the absence of maternal Nos. Furthermore, nos mutation did not affect the expression of the enhancer-trap markers in the somatic tissues listed in Table 1 (data not shown). Thus, Nos affects specific enhancer activities that are responsible for gene expression in pole cells.
Contrary to our observations, Heller and SteinmannZwicky (1998) have recently reported that the maternal Nos is not required for the expression of four enhancertrap markers including ones examined in this report (198, 640, and 4351) . This discrepancy could be due to the difference in degrees of reduction for Nos activity between the alleles used for the analyses. The strong allele, nos BN , was used here and in our previous work (Kobayashi et al., 1996) . This allele eliminates nos RNA and protein in the embryos. Furthermore, in such embryos, both pole-cell migration and abdominal formation are impaired (Wang et al., 1994; Kobayashi et al., 1996; Forbes and Lehmann, 1998) . In contrast, the embryos produced from the females homozygous for a hypomorphic allele, nos L7 , which Heller and Steinmann-Zwicky used for their analysis, show the normal distribution of nos mRNA and protein (Wang et al., 1994) . Such embryos fail to form the abdomen, but their germline development appears to be normal (Hülskamp et al., 1989; Irish et al., 1989; Struhl, 1989; Wang et al., 1994) . It has been reported that nos L7 has a mutation which deletes a small region close to the C-terminal zinc finger domain (Curtis et al., 1997) . These results suggest that this region is dispensable for Nos to regulate the gene expression in pole cells. There is a further question of how Nos protein controls the gene expression in pole cells. In the pathway leading to abdominal formation, Nos generates the abdomen by repressing the translation of maternal hunchback (hb) mRNA, which encodes a transcriptional repressor for abdominal gap genes. The translational repression by Nos requires an additional factor, Pumilio (Pum) protein, which binds directly to the discrete target sequences, or Nos Response Elements (NREs), in the 3'UTR-region of the hb mRNA (Murata and Wharton, 1995) . Recently, we found that pum mutation, like nos, affects the expression of the enhancer-trap markers in pole cells (Asaoka et al., in preparation) . This suggests that Nos cooperates with Pum in pole cells to regulate the gene expression by a translational repression mechanism. The premature expression of Type-A markers in nos pole cells can be explained by a failure of Nos to repress the production of regulatory factor(s) responsible for Type-A enhancer activation. The activator(s) may be stored in pole cells as mRNA(s) whose translation is repressed by Nos. Once maternal Nos protein disappears from pole cells at around stage 15, the activator mRNA(s) is translated to produce activator(s) for Type-A enhancers. In contrast, Nos could act as a permissive factor which allows the expression of Type-B markers in pole cells. In this model, Nos blocks the translation of mRNA(s) encoding suppressor(s) for Type-B enhancers. The suppressor mRNA(s) may be supplied maternally and translated in the embryonic cells other than pole cells to produce protein(s) required for their development. We show that the stages when the expression of Type-B markers initiates in nos pole cells are approximately identical to that observed in normal pole cells. This suggests that the activation of Type-B enhancers requires an additional factor(s), which is produced in pole cells at the correct stages, even in the absence of Nos. Further studies to determine whether Nos regulates the translation of a specific set of mRNAs in pole cells are required for clarifying the mechanisms regulating the gene expression in Drosophila germline. 
Experimental procedures
A total of 1590 enhancer-trap lines carrying single P-lwB construct at independent chromosomal loci were obtained from T. Miyake, R. Ueda and Y. Oguma. Embryos from each enhancer-trap line were stained with X-gal (5-bromo-4-chloro-3-indolyl-b-d(-)-galactopyranoside) as described previously . Embryos produced from nos BN /nos BN , nos BN /TM3 females mated with each of ten enhancer-trap lines were stained with X-gal and an antib-gal antibody (1:400 dilution, Cappel). Essentially the same staining pattern was obtained with X-gal and the antibody (data not shown). To stain pole cells, we used an antiVasa antibody. Double staining of embryos with X-gal and a rabbit anti-Vasa antibody (1:200 dilution, a gift from P. Lasko) was performed as described previously . Immunofluorescent staining of embryos was carried out as described previously (Kobayashi et al., 1998) . The dechorionated embryos were fixed in 2 ml of 1:1 mixture of heptane and fixative (4% formaldehyde in PBS (130 mM NaCl, 7 mM Na 2 HPO 4 , 3 mM NaH 2 PO 4 )) for 20 min by shaking vigorously. To increase permeability of antibodies into embryos, the fixed and devitellinized embryos were nicked in their anterior portions with a tungsten needle. Chick anti-Vasa polyclonal antibody (1:10 000 dilution, a gift from K. Howard) and a rabbit anti-b-gal polyclonal antibody (1:400 dilution, Cappel) were used. As secondary antibodies, a FITC-conjugated anti-chick antibody (1:10 dilution, KPL) and a TexasRed-conjugated anti-rabbit antibody (1:20 dilution, Amersham) were used. Stained embryos were mounted in Vectashield (Vector Lab.), then were observed under a confocal laser microscope (Leica). Embryos were staged according to CamposOrtega and Hartenstein (1985) . The nos embryos were staged by the morphology of their anterior structures and the Malpighian tubules, which are unaffected in nos embryos.
